Yamaguchi Y - Search Results

1

Dose-finding study of anti-CD25 antibody for targeting regulatory T cells in locoregional immunotherapy of malignant effusion.

Okawaki M, Yamaguchi Y, Okita R, Ohara M, Okada M. Okawaki M, et al. Among authors: yamaguchi y. Hiroshima J Med Sci. 2008 Mar;57(1):37-46. Hiroshima J Med Sci. 2008. PMID: 18578365

2

Essential requirement of toll-like receptor 4 expression on CD11c+ cells for locoregional immunotherapy of malignant ascites using a streptococcal preparation OK-432.

Hironaka K, Yamaguchi Y, Okita R, Okawaki M, Nagamine I. Hironaka K, et al. Among authors: yamaguchi y. Anticancer Res. 2006 Sep-Oct;26(5B):3701-7. Anticancer Res. 2006. PMID: 17094388 Free article.

3

Enhancement of lymphokine-activated killer cell induction using anti-CD25 and anti-CTLA-4 monoclonal antibodies.

Okita R, Yamaguchi Y, Emi A, Matsuura K, Toge T. Okita R, et al. Among authors: yamaguchi y. Oncol Rep. 2007 Jun;17(6):1429-35. Oncol Rep. 2007. PMID: 17487401

4

Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer.

Okita R, Yamaguchi Y, Ohara M, Hironaka K, Okawaki M, Nagamine I, Ikeda T, Emi A, Hihara J, Okada M. Okita R, et al. Among authors: yamaguchi y. Int J Oncol. 2009 Feb;34(2):563-72. Int J Oncol. 2009. PMID: 19148493

5

Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.

Nagamine I, Yamaguchi Y, Ohara M, Ikeda T, Okada M. Nagamine I, et al. Among authors: yamaguchi y. Hiroshima J Med Sci. 2009 Mar;58(1):37-44. Hiroshima J Med Sci. 2009. PMID: 19400555

6

The spleen plays an immunosuppressive role in patients with gastric cancer: involvement of CD62L+ cells and TGF-beta.

Noma K, Yamaguchi Y, Okita R, Matsuura K, Toge T. Noma K, et al. Among authors: yamaguchi y. Anticancer Res. 2005 Jan-Feb;25(1B):643-9. Anticancer Res. 2005. PMID: 15816640 Free article.

7

HER2-specific cytotoxic activity of lymphokine-activated killer cells in the presence of trastuzumab.

Yamaguchi Y, Hironaka K, Okawaki M, Okita R, Matsuura K, Ohshita A, Toge T. Yamaguchi Y, et al. Anticancer Res. 2005 Mar-Apr;25(2A):827-32. Anticancer Res. 2005. PMID: 15868915 Free article.

8

Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells.

Yamaguchi Y, Ohta K, Kawabuchi Y, Ohshita A, Okita R, Okawaki M, Hironaka K, Matsuura K, Toge T. Yamaguchi Y, et al. Anticancer Res. 2005 May-Jun;25(3c):2407-15. Anticancer Res. 2005. PMID: 16080467 Free article. Clinical Trial.

9

CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer.

Okita R, Saeki T, Takashima S, Yamaguchi Y, Toge T. Okita R, et al. Among authors: yamaguchi y. Oncol Rep. 2005 Nov;14(5):1269-73. Oncol Rep. 2005. PMID: 16211295

10

Intractable gastrointestinal bleeding from angiodysplasia in a patient of Bernard-Soulier syndrome--report of a case--.

Okita R, Hihara J, Konishi K, Osaki A, Yoshida K, Yamaguchi Y, Toge T, Fujimura K, Iwata T, Sawamura A. Okita R, et al. Among authors: yamaguchi y. Hiroshima J Med Sci. 2005 Dec;54(4):113-5. Hiroshima J Med Sci. 2005. PMID: 16398056

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,235 results

Search Page

Filters